Quantum BioPharma Ltd.
QNTM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $61,175 | $8,766 | $3,781 |
| - Cash | $446 | $1,498 | $3,518 | $5,996 |
| + Debt | $0 | $2,265 | $1,280 | $825 |
| Enterprise Value | – | $61,943 | $6,528 | -$1,390 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,497 | -$9,389 | -$8,260 | -$5,327 |
| % Margin | – | – | – | – |
| Net Income | -$5,319 | -$9,253 | -$8,577 | -$5,360 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.25 | -3.23 | -7.52 | -5.22 |
| % Growth | 61.3% | 57% | -44.1% | – |
| Operating Cash Flow | -$1,721 | -$1,949 | -$4,261 | -$836 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,721 | -$1,949 | -$4,261 | -$836 |